版本:
中国

BRIEF-Medtronic announces outcomes from VeClose clinical trial, ‍WAVES study​

April 25 Medtronic Plc:

* New Medtronic data demonstrate clinical and quality of life benefits for VenaSeal closure system in venous reflux disease patients

* Announced three-year outcomes from VeClose U.S. Pivotal clinical trial and one-year data from waves study

* Patients treated with either VenaSeal or ClosureFast reflected statistically significant improvement from baseline Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐